A new multitargeted drug candidate in Alzheimer disease: 1,4-dihydropyridine-benzylidenhydrazon derived AChE inhibitor
Bildiriler > Özet Bildiri · 2018
Yazarlar: Gülnur SEVİN, Elif Alançay, Sinem YILMAZ, Vildan ALPTÜZÜN, Günay YETİK ANACAK
Second WG Meeting COST ACTION CA15135, Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig), Uluslararası, Poster, Özet Bildiri, 2018-2018